ketamine has been researched along with Clinical Deterioration in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Clinical Deterioration: A critical disease progression, often measured by a set of clinical parameters, which activates HOSPITAL RAPID RESPONSE TEAM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "SC ketamine was safe and well tolerated, and most adverse events were mild and transient." | 7.01 | Potential advantages of ketamine over electroconvulsive therapy in the treatment of nonrefractory severe depression in older patients with multiple medical comorbidities. ( Cunha, UGV; Duarte, DB; Hara, C; Rocha, FL, 2023) |
| "SC ketamine was safe and well tolerated, and most adverse events were mild and transient." | 3.01 | Potential advantages of ketamine over electroconvulsive therapy in the treatment of nonrefractory severe depression in older patients with multiple medical comorbidities. ( Cunha, UGV; Duarte, DB; Hara, C; Rocha, FL, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rocha, FL | 1 |
| Cunha, UGV | 1 |
| Duarte, DB | 1 |
| Hara, C | 1 |
1 review available for ketamine and Clinical Deterioration
| Article | Year |
|---|---|
Potential advantages of ketamine over electroconvulsive therapy in the treatment of nonrefractory severe depression in older patients with multiple medical comorbidities.
Topics: Aged; Clinical Deterioration; Depression; Depressive Disorder, Major; Electroconvulsive Therapy; Fem | 2023 |